Improving patient education about tobacco withdrawal and nicotine gum use by registered nurses in inpatient psychiatry: A feasibility study by Muladore, Erin et al.
496  |   wileyonlinelibrary.com/journal/jpm J Psychiatr Ment Health Nurs. 2018;25:496–505.© 2018 John Wiley & Sons Ltd
 
Received: 23 April 2018  |  Revised: 3 August 2018  |  Accepted: 17 August 2018
DOI: 10.1111/jpm.12495
O R I G I N A L  A R T I C L E
Improving patient education about tobacco withdrawal and 
nicotine gum use by registered nurses in inpatient psychiatry: A 
feasibility study
Erin Muladore  | Jill A. Brown | Judy Haefner | Barbara Kupferschmid
University of Michigan-Flint, Flint, Michigan
Correspondence




What is known on the subject? 
• Many psychiatric inpatients use tobacco, but most psychiatric hospital units pro-
hibit tobacco use. Psychiatric nurses do not receive adequate education about 
how to teach patients to best manage tobacco withdrawal symptoms.
What does this paper add to existing knowledge? 
• Psychiatric nurses who receive a brief educational intervention about tobacco 
withdrawal symptoms and best practices for using nicotine gum may be more 
prepared to teach patients about these topics. In turn, patients may use nicotine 
gum more often during their hospitalization, leading to improved outcomes for 
them as well as for staff.
What are the implications for practice? 
• A simple educational intervention aimed at psychiatric nurses can result in positive out-
comes for psychiatric inpatients who use tobacco. Patients who have a positive experi-
ence with stopping tobacco use while hospitalized may be more likely to commit to 
lifelong tobacco cessation afterwards. The results of this feasibility study demonstrate 
that additional research that builds on the work presented here is warranted.
Abstract
Introduction: Tobacco use is prohibited in most psychiatric facilities in the United 
States, yet many psychiatric inpatients are tobacco users. Psychiatric nurses have re-
ported inadequate education about best practices for managing tobacco dependence.
Aim: To explore the feasibility of an educational intervention for psychiatric nurses 
designed to improve their ability to educate patients about best practices for manag-
ing tobacco dependence, as well as effective use of nicotine gum.
Method: Fourteen nurses on a psychiatric inpatient unit at a community hospital 
were educated about the targeted topics. Chart reviews of nonequivalent pre- 
intervention and post- intervention patient groups were conducted to explore the 
outcomes of the intervention.
Results: Patients received more teaching, and used nicotine gum more often, follow-
ing the intervention. However, no statistically significant differences between the 
pre- intervention and post- intervention patient groups were found.
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1  | INTRODUC TION
Tobacco use in the United States, the United Kingdom and Australia 
is two to four times higher among those with a diagnosed mental 
disorder than among the general population (Mendelsohn, Kirby, & 
Castle, 2015; Prochaska, Das, & Young- Wolff, 2017; Prochaska, Hall, 
Delucchi, & Hall, 2014). In the United States, while most psychiatric 
facilities prohibit smoking on their premises (Prochaska et al., 2017), 
approximately 44% of tobacco users have a mental health diagnosis 
(Prochaska, Gill, & Hall, 2004) and between 42% and 60% of admit-
ted inpatients are current smokers (Leyro et al., 2013). Thus, many 
of those admitted to inpatient units struggle to remain tobacco free 
during their hospitalization. Since the half- life of nicotine is about 
2 hrs, symptoms of withdrawal from tobacco products typically 
begin within 24 hrs of the last use (American Psychiatric Association 
[APA], 2013; Robson et al., 2017). Fifty per cent of tobacco users 
develop withdrawal symptoms following cessation, meaning that at 
least 22% of those admitted for inpatient psychiatric treatment will 
likely experience tobacco withdrawal concurrent with a psychiatric 
crisis (APA, 2013). This sets the stage for a multitude of potential 
challenges for patients and staff, as described later in this paper.
As of 2011, the average length of stay for a psychiatric admission 
in the United States was 5 or 6 days (Glick, Sharfstein, & Schwartz, 
2011). Patients who experience tobacco withdrawal as a conse-
quence of psychiatric hospitalization will likely endure the worst of 
these symptoms during inpatient treatment for comorbid mental 
health issues, so optimal management of withdrawal symptoms is 
essential.
Abstinence from tobacco products results in a pattern of with-
drawal symptoms that begins as wanting, progresses to craving and 
ends with a need to use again (DiFranza, Ursprung, & Biller, 2012). 
These symptoms can begin as rapidly as a few hours after nico-
tine abstinence, peak between 2 and 7 days, and may continue for 
10 days to 1 month (APA, 2013; McLaughlin, Dani, & De Biasi, 2015; 
Paolini & De Biasi, 2011; Soyster, Anzai, Fromont, & Prochaska, 
2016). Cravings—which involve a persistent desire to use tobacco, 
unpleasant physical sensations, and disrupted concentration—are 
at their most intense shortly after a quitting attempt but can linger 
for years even for those who have successfully quit using tobacco 
(Carpenter et al., 2013; Hughes, 2010).
During detoxification from a substance such as tobacco, absti-
nence may or may not be a goal of the user (Diaper, Law, & Melichar, 
2013). In the case of inpatients who are not allowed to smoke, de-
toxification is a consequence of hospital policy rather than a self- 
selected and self- directed step towards long- term abstinence. 
Therefore, patients in the psychiatric inpatient setting may struggle 
not only with the symptoms of tobacco withdrawal, but also with 
finding motivation to participate in managing their withdrawal. 
However, patients admitted to the hospital for inpatient psychiatric 
treatment benefit most when they are actively engaged in decision- 
making about their care, including engaging in tobacco cessation 
(Duncan et al., 2016).
The effects of tobacco withdrawal are somatic, cognitive and 
affective and the experience is well- known to be challenging even 
for those without mental illness (Frandsen, Thorpe, Shiffman, & 
Ferguson, 2017). These symptoms can be so severe that coping 
with them has been equated with enduring a psychiatric crisis 
(Frandsen et al., 2017). As a result, many people addicted to to-
bacco continue to use it rather than face the formidable difficul-
ties that come with quitting. For patients admitted to an inpatient 
psychiatric unit, the simultaneous combination of coping with a 
psychiatric crisis and involuntary abstinence from tobacco can re-
sult in acute stress that manifests physically, mentally and emo-
tionally (Frandsen et al., 2017). In light of this clinical picture, the 
need to address tobacco withdrawal in the inpatient setting be-
comes abundantly clear.
Having a mental illness increases the likelihood of experienc-
ing symptoms of withdrawal when abstaining from tobacco (APA, 
2013; Ameringer & Leventhal, 2015; Leventhal, Ameringer, Osborn, 
Zvolensky, & Langdon, 2013; Smith, Homish, Giovino, & Kozlowski, 
2014; Soyster et al., 2016). Individuals with psychiatric disorders may 
be unusually sensitive to tobacco cessation, leading to withdrawal 
symptoms that occur sooner after abstinence than in those without 
psychiatric diagnoses (Ameringer & Leventhal, 2015). Those with 
depressive disorders, anxiety disorders, bipolar disorders, attention- 
deficit/hyperactivity disorder and other substance use disorders are 
Discussion: Educating nurses about best practices for managing tobacco withdrawal 
symptoms may have positive outcomes. Existing research suggests that such inter-
ventions may be most effective when support and structure are provided to ensure 
long- term practice changes.
Implications for practice: This feasibility study demonstrates that a brief nurse edu-
cation intervention has the potential to improve the experience of tobacco with-
drawal for psychiatric inpatients. Future research that expands upon the current 
project is warranted.
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most likely to experience severe symptoms of tobacco withdrawal 
(APA, 2013).
Tobacco withdrawal symptoms are believed to be caused by de-
creased levels of both dopamine and norepinephrine (Kawai et al., 
2017). Irregularities in these catecholamines are also involved in 
many psychiatric diagnoses, including depressive and anxiety disor-
ders, bipolar disorder, schizophrenia and gambling disorder (Cousins, 
Butts, & Young, 2009; Felger & Lotrich, 2013; Hook et al., 2014; 
Mittal et al., 2017; Potenza, 2013). The fact that dysregulations in 
these neurotransmitters are involved in both tobacco withdrawal 
and psychiatric disorders fortifies the argument that tobacco with-
drawal is more complex for tobacco users with comorbid psychiatric 
disorders than for those without (APA, 2013; Reynolds, McGowan, 
& Dalton, 2013; Yamamoto, Shinba, & Yoshii, 2014). Given the phys-
iologic factors involved, these patients may have trouble controlling 
their actions; even a brief period of tobacco withdrawal can result 
in a heightened neural response to stress (Ashare et al., 2016). This 
complex interplay between the symptoms of psychiatric disorders 
and the symptoms of tobacco withdrawal point to the need to edu-
cate and support inpatients experiencing both causes of symptoms 
during hospitalization.
The affective signs and symptoms of tobacco withdrawal are not 
specific to tobacco withdrawal itself (DiFranza & Ursprung, 2008). 
They are often similar or identical to the signs and symptoms of a 
variety of psychiatric disorders (APA, 2013). DiFranza and Ursprung 
(2008) raised the question of how clinicians can be certain that to-
bacco users are correctly differentiating the affective symptoms of 
tobacco withdrawal from affective states unrelated to withdrawal. 
They concluded that because tobacco users experience withdrawal 
symptoms repeatedly and because these symptoms resolve with 
tobacco use, smokers know exactly when they are experiencing to-
bacco withdrawal (DiFranza & Ursprung, 2008).
Signs and symptoms caused by tobacco withdrawal include ir-
ritability, frustration, anger, anxiety, difficulty concentrating, in-
creased appetite, restlessness, depressed mood and insomnia (APA, 
2013; Frandsen et al., 2017). While most common among daily users, 
withdrawal symptoms can occur even among those who use tobacco 
on a less than daily basis (APA, 2013). The overlap between these 
symptoms and those of other mental disorders can result in a lack of 
clarity with regard to assessment, patient care and treatment plans 
(Leyro et al., 2013; Soyster et al., 2016). Additionally, according to 
the DSM-5 tobacco use can increase the serum levels of many psy-
chotropic medications, which can also lead to clinically significant 
outcomes (APA, 2013). Thus, tobacco cessation that is inadequately 
managed in the inpatient psychiatric setting is an issue which needs 
to be addressed for patients, clinicians and registered nurses (RNs).
Staff working with patients in inpatient psychiatric settings 
need to be aware that symptoms attributed to psychiatric disorders 
can be caused by tobacco withdrawal, and vice versa; it is common 
for symptoms of the two to be confounded during the assessment 
process (APA, 2013; Ameringer & Leventhal, 2015; Leventhal et al., 
2013; McLaughlin et al., 2015; Robson et al., 2017; Smith et al., 2014; 
Soyster et al., 2016). As a result, when tobacco withdrawal is treated 
inadequately during hospitalization, psychiatric diagnoses may be in-
correct or incomplete (Soyster et al., 2016). Tobacco withdrawal also 
introduces the possibility that inaccurate assessment of treatment 
efficacy will occur. Patients who are required to stop using tobacco 
at the time of hospitalization may experience a gradual decrease in 
tobacco withdrawal symptoms following an initial period of acute 
exacerbation (Soyster et al., 2016). When this occurs, these dimin-
ished symptoms may be attributed to the treatment provided for the 
admitting diagnoses rather than to an improvement in the symptoms 
of tobacco withdrawal (Soyster et al., 2016). A diagnosis of tobacco 
withdrawal can be confirmed in the case of symptoms that decrease 
with the use of nicotine replacement therapy (NRT; APA, 2013).
Both patients and staff RNs must understand that treating 
the acute symptoms of tobacco withdrawal is a collaborative task. 
Ideally, nurses educate patients about tobacco withdrawal and op-
tions available to treat it, while patients exercise these options in 
ways that are most effective for them. Unfortunately, recent re-
search demonstrated that levels of NRT received by patients on 
psychiatric units are often suboptimal; additionally, psychiatric RNs 
reported that they did not have enough training to provide these 
medications in an effective manner (Thomas & Richmond, 2017). 
Thomas and Richmond (2017) called for the implementation of 
staff training for managing tobacco dependence among psychiat-
ric inpatients. The clinical guideline published by the United States 
Department of Health and Human Services (USDHHS, 2008) of-
fers one of the most recent sets of recommendations for NRT use. 
Evidence has demonstrated that higher- dose nicotine patches, gum 
and lozenges are the most efficacious for highly dependent patients; 
a combination of NRT products may be particularly helpful for this 
population (USDHHS, 2008).
There is a need to ensure that staff RNs are educated about 
the signs and symptoms of tobacco withdrawal and how these may 
contribute to patient behaviours that interfere with the ability to 
fully engage in treatment. Staff RNs working with these patients 
also need to understand the ways in which the symptoms of to-
bacco withdrawal can lead to incorrect or incomplete diagnoses, 
as well as inaccurate assessments of treatment efficacy for psy-
chiatric disorders. Equipped with this information, RNs will be 
prepared to educate patients about the consequences of tobacco 
withdrawal as well as about best practices for managing it during 
hospitalization.
While protocols exist to assist clinicians with choosing the ap-
propriate type, route, schedule and dosage of NRT for patients, de-
cisions about whether and how often to make use of prn (as- needed) 
forms of NRT are typically made by patients at the discretion of 
nursing staff. If NRT is not ordered, if patients make inadequate use 
of the prn NRT regimen available to them, or if the type of nicotine 
replacement necessary to meet a patient’s needs is not available, 
patients are likely to struggle with the sequelae of tobacco with-
drawal during their hospitalization. In extreme cases, patients have 
been known to elope from the hospital in order to resume smoking 
(Stiebel & Nightengale, 2013). In other serious cases, patients are 
put into seclusion or restraints due to behaviours that are rooted in 
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unbearable withdrawal symptoms caused by the abrupt cessation of 
nicotine (Belluck, 2013; Lawn & Pols, 2003; Stiebel & Nightengale, 
2013).
Nicotine gum is considered a “rescue medication” for smokers 
experiencing intense cravings for nicotine and is one of the best 
options available for the management of acute symptoms of with-
drawal (Mendelsohn, 2013; Shiffman et al., 2003; USDHHS, 2008). 
It is a broadly- accepted form of NRT due to its safety, familiarity, and 
the fact that users have control over the timing of its effects vis- a- 
vis their acute nicotine cravings (Shiffman et al., 2009). Additionally, 
it is effective both physically and psychologically; Shiffman et al. 
(2003) demonstrated that nicotine gum was effective in reducing 
cravings and that the mechanism was pharmacological, not merely 
behavioural.
Tobacco users are accustomed to self- regulating their dose 
of nicotine throughout the course of the day, and to experi-
encing the effects of nicotine intake within seconds of inges-
tion (Frandsen et al., 2017; Schneider et al., 2006; USDHHS, 
2014). Smoking allows tobacco to be absorbed through the ar-
terial blood stream and enables nicotine to reach the brain al-
most instantaneously; in contrast, NRT products are absorbed 
through the systemic venous system and thus require minutes 
to hours to take effect (Molyneux, 2004; Subramaniyan & Dani, 
2015). However, nicotine gum is one of the faster forms of NRT, 
controlling acute cravings within 15–20 min of initiation of use 
(Shiffman et al., 2009).
Despite taking longer to mitigate the symptoms of tobacco 
withdrawal than can be accomplished with smoking, nicotine gum 
has been theorized to be effective in reducing symptoms of to-
bacco withdrawal including irritability, anxiety, poor concentra-
tion, sleep disturbance, hunger, craving for nicotine and overall 
withdrawal discomfort (Mendelsohn, 2013; West & Shiffman, 
2001). In one study of psychiatric inpatients who resumed smok-
ing following hospitalization, 70% made use of NRT during their 
hospital admission (Prochaska, Fletcher, Hall, & Hall, 2006). These 
patients identified nicotine replacement medications as being ben-
eficial for their effects on the symptoms of tobacco withdrawal 
rather than for their potential to assist with smoking cessation 
(Prochaska et al., 2006). For patients who require management of 
the acute effects that occur with abrupt cessation of tobacco use, 
nicotine gum is an essential intervention whose importance must 
not be overlooked.
Given the existing knowledge about the interplay between psy-
chiatric illnesses and tobacco use, the ongoing lack of training for 
RNs about the use of nicotine replacement medications in this pa-
tient population, and the availability of a commonly available and 
low- risk rescue medication whose use can be optimized as a partial 
solution to the many challenging sequelae of tobacco withdrawal 
among patients admitted to inpatient psychiatric units, an explor-
atory study designed to investigate the feasibility of a randomized 
controlled trial was identified as a project that would add value to 
the psychiatric and mental health nursing literature.
2  | RESE ARCH AIM/QUESTION
Following Tickle- Degnen (2013), our overarching objective was to 
understand the factors that might arise in conducting a more rigor-
ous and larger- scale study of a RN- driven patient education inter-
vention related to tobacco withdrawal and nicotine gum use in the 
inpatient psychiatric setting. To this end, the specific purpose of our 
feasibility study was twofold: first, to educate staff RNs working on 
a behavioural health unit at a medium- sized community hospital 
in the United States about (a) the signs and symptoms of tobacco 
withdrawal, (b) the process of requesting nicotine gum on a prn 
basis for the treatment of acute symptoms of tobacco withdrawal 
and (c) best practices for using nicotine gum. Second, we aimed to 
increase RN- provided patient education on these same topics as 
evidenced by increased documentation by nurses. We also wanted 
to understand whether patients who received this education would 
request nicotine gum more often as compared with an equivalent 
patient population during an equivalent, pre- intervention period of 
time.
The organization has a hospital- wide nursing policy which ad-
dresses assisting patients with reducing or stopping smoking, based 
on a clinical practice guideline published by the U.S. Public Health 
Service (USDHHS, 2008) and additional information published by 
an equivalent organization at the statewide level. The policy out-
lines the 5 As Model for treating tobacco use and dependence but 
does not indicate when or how often patient teaching should occur. 
Although the policy specifies that RNs providing this education 
should document their interventions, it was observed that chart-
ing related to patient education about tobacco use and NRT varied 
greatly from nurse to nurse. In addition, it was noted that there was 
no area in the electronic chart specifically designated for document-
ing such education.
This feasibility study entailed implementation of an educational 
intervention for psychiatric nurses working with inpatients enduring 
comorbid tobacco withdrawal and possible exacerbation of psychi-
atric symptoms. In so doing, this project aimed to provide insight into 
the extent to which this education of RNs about tobacco withdrawal 
and the use of nicotine gum to treat acute cravings for tobacco 
would result in increased patient education about these topics, as 
well as an increase in the use of nicotine gum to manage acute symp-
toms of tobacco withdrawal.
3  | METHODS
3.1 | Participants
The nurse participants in this project were the staff RNs on a 24- 
bed psychiatric inpatient unit at a medium- sized community hospital 
in Southeastern Michigan. Fourteen RNs (56%) of the 25 nurses on 
staff participated in the project. Exclusion criteria were RNs who did 
not work a shift during the post- intervention phase and those who 
declined to participate.
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Patient participants consisted of a pre- intervention compari-
son group and a post- intervention group. All patients were adults 
age 18 and older who were hospitalized on the unit during the pre- 
intervention or post- intervention phases and had used a tobacco 
product within the 30 days preceding their admission. The 30- day 
window was derived from the definition of tobacco use specified in 
the tobacco treatment measure set of The Joint Commission (2017; 
Smith, Cobb, & Corso, 2013).
3.2 | Ethical considerations
Each nurse participant signed an agreement providing informed 
consent to participate in the study, acknowledging that they were 
under no obligation to take part in the project and that the data 
would be confidential. All data related to patients were acquired 
through chart reviews. Project leaders were trained in responsi-
ble conduct of research by completing certification through the 
University of Michigan Program for Education and Evaluation in 
Responsible Research and Scholarship. The study protocol was 
determined to be a quality improvement project and was there-
fore granted exemption status by the institutional review board 
of the participating hospital and the University of Michigan- 




The project consisted of a pre- intervention and post- intervention 
phase of 31 days each. The pre- intervention phase took place pri-
marily during January 2018, while the post- intervention phase 
spanned mid- February to mid- March, 2018. Data were collected 
about all instances of staff RN documentation of patient teaching 
about the aforementioned topics. In addition, data about the fre-
quency, dosing and timing of nicotine gum administrations were also 
collected, as well as limited demographic information about patients 
who met the inclusion criterion of being a recent tobacco user. All 
data were de- identified to protect the privacy of the RNs and pa-
tients involved.
3.3.2 | RN education intervention
The study intervention consisted of educating staff RNs about how 
to teach psychiatric inpatients about (a) the signs and symptoms of 
tobacco withdrawal, (b) the process of requesting nicotine gum on 
a prn basis for the treatment of acute symptoms of tobacco with-
drawal and (c) best practices for using nicotine gum. RNs who con-
sented to participate in the project were instructed about the details 
of their role in the project, as well as the underlying rationales for the 
information to be taught to patients.
RNs were educated during a session held on the unit during 
the time designated for a regularly scheduled staff meeting. Two 
brief videos, one summarizing the pathophysiology of tobacco 
withdrawal and the other explaining the pharmacodynamics of 
NRT (Quit Victoria, 2017a, 2017b), were viewed by the RN partic-
ipants to refresh their knowledge in these areas. RNs were then 
provided with a handout to use when educating patients about to-
bacco withdrawal and nicotine gum use. Nurses were instructed 
to provide each patient with a copy of the handout within 24 hrs 
of arrival on the unit, and suggestions about how to teach the in-
formation were provided and discussed. RNs were asked to obtain 
teach- back from patients. Teach- back is a method that entails hav-
ing patients restate information in their own words to confirm that 
it has been understood correctly (Agency for Healthcare Research 
and Quality, n.d.).
Nurse participants were then educated about the need to doc-
ument their patient teaching, and given verbal instructions and a 
handout with specific instructions about how and where to chart 
this information in the electronic health record. RN participants 
were reminded that they should chart only what they taught so their 
documentation would accurately reflect the patient teaching that 
took place.
4  | RESULTS
This study used a nonequivalent groups pretest–posttest design 
to compare pre- intervention control data with equivalent post- 
intervention data.
4.1 | Patient characteristics
Characteristics of the patients whose charts were reviewed are pre-
sented in Table 1. Data about tobacco use were based on what was 
available for each patient. Of note, many of the tobacco use histo-
ries completed by nurses at admission were incomplete to varying 
degrees.
The pre- intervention group consisted of 24 patients with ages 
ranging from 18 to 69 years. The most common categories of psy-
chiatric diagnoses assigned during the current admission for these 
patients were substance use disorders (54.2%), depressive disorders 
(50.0%) and anxiety disorders (37.5%). The ages at which these pa-
tients began using tobacco ranged from 11 to 18, with all but one pa-
tient in this group being cigarette smokers (95.8%). Only one patient 
(4.2%) used more than one form of tobacco. The number of packs 
(defined as 20 cigarettes) per day for cigarette smokers ranged from 
0.2 to 2. The number of years of tobacco use varied widely, from 3 
to 45 years. The average inpatient length of stay for this group was 
4.7 days.
The post- intervention group had 30 patients who spanned 
19–66 years of age. The three most common categories of psychi-
atric diagnoses during their admission to the unit were depressive 
disorders (70.0%), anxiety disorders (46.7%) and substance use 
disorders (43.3%). These patients began using tobacco from ages 9 
through 40 years. All but two used cigarettes, while three patients in 
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the group used more than one form of tobacco. The quantity of cig-
arettes smoked ranged from 0.2 to 2 packs per day, and the ages at 
which they began smoking ranged from 9 to 40 years. The durations 
for which they had used tobacco ranged from 3 to 45 years. The av-
erage inpatient length of stay for this group was 6.5 days.
A summary of patient outcomes describing the number and per-
centage of patients who received nicotine gum only, patient educa-
tion only, or both, is presented in Table 2.
4.2 | RN documentation of patient education
During the pre- intervention phase of the project, RNs documented 
just one instance of teaching about any of the topics that were in-
cluded in the RN education intervention. This teaching consisted 
of educating one patient (4.2%) about the use of nicotine patches. 
Following the RN education intervention, this number increased 
with seven patients (23.3%) in the post- intervention group being 
educated about the three topics that were the focus of the educa-
tion intervention provided to RNs.
4.3 | NRT use
On the psychiatric inpatient unit where the project took place, nico-
tine gum is available in a 2 mg dose. One or two pieces of gum are 
given per administration, depending on the dose ordered by the 
prescribing physician. All nicotine gum administered on the unit oc-
curs on a prn basis, meaning that patients use it when they feel it 
is appropriate or when its use is suggested by an RN and the pa-
tient is in agreement. NRT is also available in the form of nicotine 
patches, in doses of 21, 14 and 7 mg; when ordered, this medica-
tion is administered on a daily basis with patients having the right 
to refuse its use. Nicotine patches and nicotine gum may be used 
individually or together, at the discretion of the prescriber. During 
the pre- intervention phase, a total of 215 administrations of nico-
tine gum occurred. They were divided between 203 (94.4% of total 
administrations) at the 2 mg dose and 12 (5.6%) at the 4 mg dose. 
In contrast, during the post- intervention phase, RNs supplied 248 
TABLE  1 Sample characteristics by group
Variable
Total (N = 54) Pre- intervention (n = 24) Post- intervention (n = 30)
N % n % n %
Gender
Female 24 44.4 11 45.8 13 43.3
Male 30 55.5 13 54.2 17 56.7
Age
<35 31 57.4 15 62.5 16 53.3
≥35 23 42.6 9 37.5 14 46.7
Psychiatric diagnosis
Anxiety disorder 23 42.6 9 37.5 14 46.7
Depressive disorder 33 61.9 12 50.0 21 70.0
Substance use disorder 26 48.1 13 54.2 13 43.3
Tobacco use
Cigarettes 51 94.4 23 95.8 28 93.3
Cigars 3 5.6 2 8.3 1 3.3
Chewing tobacco 2 3.7 0 0 2 6.7
E- cigarettes 2 3.7 0 0 2 6.7
>1 form of tobacco 4 7.4 1 4.2 3 10.0
M SD M SD M SD
Age of smoking initiation 16 5.1 15.1 1.9 16 6.7
Cigarette packs per day 0.9 0.5 0.9 0.5 0.9 0.5
Years of tobacco use 17 11.1 19 14.6 15.8 9.2







n % n %
Patients receiving teaching 
only
1 4.2 7 23.3
Patients receiving nicotine 
gum only
12 50.0 21 70.0
Patients receiving teaching 
and nicotine gum
0 0.0 6 20.0
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doses of nicotine gum to patients. 185 (74.6% of total administra-
tions) of these were in the amount of 2 mg, while the remaining 63 
(25.4%) were 4 mg.
4.4 | Statistical analysis
Data were cross- tabulated and analysed for statistical significance 
using SPSS. The Pearson chi- squared test and Fisher’s exact test 
were used as appropriate to understand whether the relationships 
between specific variables were statistically significant pre- and 
post- intervention. An alpha level of 0.05 was used to assess statisti-
cal significance for all analyses.
A chi- squared test revealed that there was no statistically 
significant difference between the pre- intervention and post- 
intervention groups in terms of gender or age. The pre- intervention 
group was 45.8% female, while the post- intervention group was 
43.3% female (p = 0.854). Individuals under age 35 comprised 
62.5% of the pre- intervention group as compared with 53.3% of 
the post- intervention group (p = 0.498). In terms of psychiatric 
diagnoses, a chi- squared test revealed that, although the differ-
ences between the groups were not statistically significant, with 
p = 0.462 for substance use disorders and p = 0.713 for anxiety 
disorders, the p- value of 0.073 for depressive disorders was no-
table given that it approached statistical significance. Diagnoses 
were considered on a standalone basis, and the presence of mul-
tiple psychiatric diagnoses in individual patients was not included 
as part of the statistical analysis.
A Fisher’s exact test revealed that there were no statistically sig-
nificant differences between pre- intervention and post- intervention 
patients in terms of the type of tobacco used. Cigarette (p = 1.000), 
cigar (p = 0.579), chewing tobacco (p = 0.497), and e- cigarette 
(p = 0.497) use were all examined. Similarly, there was no statistical 
difference between the two groups among those who used more 
than one form of tobacco; using Fisher’s exact test to test this com-
parison yielded p = 0.620.
Patients in the pre- intervention group were compared with pa-
tients in the post- intervention group in terms of the percentage for 
whom documentation of teaching by an RN about tobacco with-
drawal and nicotine gum use occurred. Fisher’s exact test revealed 
no statistically significant difference between the groups for this 
factor, with 4.2% receiving teaching prior to the intervention and 
23.3% receiving teaching after (p = 0.063). The chi- squared test was 
used to compare the percentages of patients who received nicotine 
gum before and after the RN education intervention. In the pre- 
intervention group, 50.0% of patients received nicotine gum while 
70.0% of those in the post- intervention group were administered 
this medication (p = 0.134). An additional cross- tabulation was cre-
ated to compare patients who received both RN teaching and nico-
tine gum. There was a shift from the pre- intervention phase to the 
post- intervention phase in that more patients received both teach-
ing and gum after the intervention than before. Given that fewer 
than five patients were in each of these groups, a p- value cannot 
be reported for this comparison. For patients who received either 
teaching or gum, no statistically significant difference was found 
using a chi- squared test (p = 0.143).
5  | DISCUSSION
This study was planned with the primary goal of evaluating the feasi-
bility of additional research on RN- led efforts to educate psychiatric 
inpatients about tobacco withdrawal and the use of nicotine gum to 
reduce the negative outcomes that can result from undertreatment 
of tobacco withdrawal symptoms. As such, the project involved the 
implementation of an education intervention for RNs in order to in-
vestigate its effects on two quality improvement- based outcomes: 
documentation of teaching about tobacco withdrawal and its symp-
toms as well as best practices for nicotine gum use; and nicotine 
gum use by psychiatric inpatients. By examining these outcomes, we 
aimed to provide insight into the extent to which education provided 
by nurses to patients enduring comorbid tobacco withdrawal and 
exacerbation of psychiatric symptoms would be useful for helping 
psychiatric inpatients manage acute withdrawal symptoms.
Although our analysis revealed that there was no statistically 
significant difference between the pre- intervention and post- 
intervention patients with regard to documentation of teaching by 
RNs, there was a notable increase of 19.1% in the number of patients 
who received teaching (one pre- intervention patient, as compared 
with seven post- intervention patients). Similarly, there was an in-
crease, although not statistically significant, in the percentage of pa-
tients who received nicotine gum following the intervention. 50.0% 
of pre- intervention patients received nicotine gum, while 70.0% 
received this medication after the intervention for an increase of 
20.0%. Finally, although the number of patients who received both 
teaching and nicotine gum was not statistically significant, there was 
a marked increase of 20.0%; 0 pre- intervention patients received 
both, while six post- intervention patients were in this category.
Wye, Stockings, Bowman, Oldmeadow, and Wiggers (2017) 
demonstrated that provision of training, education and feedback 
to clinical staff resulted in long- term practice changes in terms of 
tobacco use assessment, provision of advice on cessation and pre-
scribing of NRT to psychiatric inpatients both during admission and 
at discharge. Their study included a practice change support offi-
cer who managed the implementation of project strategies and re-
sources (Wye et al., 2017), suggesting that staff asked to add new 
tasks to their practice may be most successful with structure and 
support beyond what we were able to provide.
It is possible that RNs participating in this project performed 
patient education on the target topics more often than was docu-
mented; the results in Table 2 speak to the likelihood that there was 
a discrepancy between what nurses did and what they documented 
doing. Myklebust, Bjørkly, and Råheim (2017) described the gap that 
exists between the care psychiatric nurses provide to patients and 
how (and whether) they document that care. According to Lewin’s 
classic force field model, one of the requirements for change is 
that participants link motivation to action (Lewin, 1947). Given the 
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short- term nature of this project, nurses on the unit may have lacked 
sufficient motivation to take action and perform the additional tasks 
of patient teaching about the areas of focus. Alternatively, it is pos-
sible that some nurses participating in the project taught patients 
about the topics addressed in the nurse education intervention but 
neglected to document that teaching.
5.1 | Limitations
There were some obvious limitations in the design of our study that 
affected the interpretations of the data we collected. Given the 
time- limited nature of the pre- and post- intervention phases, our 
sample sizes were ultimately too small to yield statistically signifi-
cant results. Despite this, some intriguing trends emerged. A future 
study of longer duration would offer the opportunity to re- examine 
this topic with a larger group of patients, thus providing additional 
insight into the issues we examined.
The use of chart reviews to measure patient teaching was an-
other limiting factor to the study. Although the use of chart reviews 
to measure whether patient teaching occurred is common practice 
in healthcare research, there are a number of disadvantages, in-
cluding incomplete and missing data (Gregory & Radovinsky, 2012); 
these were factors in our study. Our reliance on chart reviews also 
precluded us from following up with patients following their dis-
charge, which might have revealed longer- term outcomes related 
to the study. Additional measures of whether patient teaching oc-
curred could have included direct observation of patient teaching, 
or patient report, although these methods would present their own 
challenges.
6  | IMPLIC ATIONS FOR PR AC TICE
This project was intended as a feasibility study and was carried out 
at a community hospital in the United States. For these reasons, the 
results should not be generalized to other settings. However, our 
findings have implications for psychiatric inpatient units worldwide. 
Given that tobacco is universally harmful—and fatal for a third of its 
users—abstinence from it is a goal that applies equally to those with 
psychiatric diagnoses and those without (Basu, Mitra, & Vadivelu, 
2015). There has been increased recognition in the scientific lit-
erature of the inequities of tobacco treatment that have persisted 
between psychiatric populations and the general public (Prochaska 
et al., 2017). This continues to be the case despite clinical practice 
guidelines and standards of care issued by accrediting bodies and 
professional organizations which emphasize the need to treat to-
bacco dependence among patients with psychiatric disorders (APA, 
2010; USDHHS, 2008). Therefore, both clinicians and nurses must 
take seriously the imperative to fully address the sequelae of to-
bacco cessation that occur for many patients during inpatient psy-
chiatric hospitalization.
Our study highlights the fact that a brief educational interven-
tion using minimal resources, directed at RNs, has the potential 
to improve the experience of tobacco withdrawal for psychiatric 
inpatients. Improved patient and unit outcomes can be achieved 
through an increased focus on the vital roles patient education 
and nicotine gum—a rescue medication for tobacco withdrawal—
play in the overall clinical picture for this population. While our 
study did not focus on long- term cessation from tobacco, a pos-
itive experience with managing the symptoms of tobacco with-
drawal during hospitalization may empower patients to pursue this 
as a long- term goal. Based on the findings of this feasibility study, 
future research exploring the role of RN education as related to 
patient teaching about management of tobacco withdrawal symp-
toms during inpatient psychiatric hospitalization is warranted. 
Larger sample sizes (of both patients and nurses), longer- term 
studies, and those incorporating follow- up with patients would all 
be useful next steps that would help expand on the results of this 
project.
Hospitalization due to psychiatric illness is a stressful event. 
For patients who use tobacco, the requirement that they ab-
stain from engaging in a tried- and- true coping mechanism while 
dealing with the aftermath of a psychiatric crisis poses an addi-
tional challenge. While cessation from tobacco is the ultimate 
tobacco- related goal for these patients, the primary goal during 
hospitalization should be that of optimizing management of any 
withdrawal symptoms that arise during this time. From there, pa-
tients will be better positioned to work with outpatient mental 
health providers to commit to, and achieve success with, lifelong 
tobacco cessation.
7  | RELE VANCE STATEMENT
This feasibility study highlights the fact that a brief intervention 
using minimal resources, directed at registered nurses, has the po-
tential to improve the experience of tobacco withdrawal for psy-
chiatric inpatients. Improved patient and unit outcomes may be 
achieved through an increased focus on the vital roles that patient 
education and nicotine gum—a rescue medication for tobacco with-
drawal—play in the overall clinical picture for this population. A posi-
tive experience with managing the symptoms of tobacco withdrawal 
during hospitalization may empower patients to pursue tobacco ces-
sation as a long- term goal.
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